Abstract
To the Editor. —Although the safety of more than 20 million units of blood products transfused in the United States each year has improved through modifications in donor screening and testing in response to the human immunodeficiency virus epidemic, residual risk remains for acquisition of infection caused by emerging pathogens, including Yersinia enterocolitica . 1,2 Report of a Case. —In March 1997, a 57-year-old man with acute granulocytic leukemia was transfused with a unit of pooled platelet concentrate. Forty-five minutes after the infusion began, the patient developed severe rigors; the transfusion was stopped. Bacterial contamination of the platelet concentrate was suspected. Although Gram stain of the unit was negative, culture of the remaining platelet concentrate yielded Y enterocolitica , serotype 0:3. Blood cultures drawn at the time of the reaction, while the patient was receiving imipenem and gentamicin, did not grow bacteria. Six donors contributed to the pooled platelet unit. Of the
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
More From: JAMA: The Journal of the American Medical Association
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.